We would like to thank our sponsors.
Kowa Company, Ltd. is a multinational company headquartered in Nagoya, Japan. Since its founding in 1894 as a cotton fabric wholesaler, Kowa Group has grown into a global enterprise with more than a 120-year history. Kowa Company Ltd., as the core of the Group, is actively engaging in various business fields including the trading of textiles, machinery, and construction materials, in addition to the manufacturing and sales of medicines, medical equipment, and energy saving products. Especially, the pharmaceutical field is positioned as the key business segment: Prescription drugs (ethical drugs), Over-the-Counter (OTC) drugs / consumer healthcare products / dietary supplements, and medical equipment. Moreover, the pharmaceutical R&D division is focused on research and development for cardiovascular (dyslipidemia, type 2 diabetes and atherosclerosis), ophthalmic, and anti-inflammatory agents. For more information, please visit <www.kowa.co.jp/eng>.
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan.
SYSMEX CORPORATION works to contribute to the development of healthcare and healthy lives of people in more than 190 countries and regions around the world.
We will continue taking on the challenge of creating high-value testing and diagnostic technologies to help resolve world’s medical issues and to contribute toward the realization of a sustainable society.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Eli Lilly Japan K.K. is a subsidiary of US-based Eli Lilly and Company. It contributes to medical treatment in Japan through the development, manufacture, import and sale of innovative pharmaceutical products that enable people to live longer, healthier, and more fulfilling lives, focusing on the therapeutic areas such as cancer, diabetes, musculoskeletal diseases, central nervous system diseases, autoimmune diseases, growth disorder, and pain.